BioMedWire Stocks

Hair Loss in Women May Indicate Other Conditions

Pattern hair loss is a common condition that affects men as well as millions of women. Losing hair can be caused by many things, ranging from stressful events to changes in an individual’s hormones. The most common cause of hair loss is a hereditary condition that causes the hair to thin at the top of an individual’s scalp.

The condition may also indicate the presence of health issues, said Dr. Valerie Callender. Callender is a dermatology professor at the College of Medicine, Howard University and an expert at the American Academy of Dermatology.

In a recent academy news release, Callender provided information on the different variations of hair loss observed in females with darker skin. She also discussed the common conditions linked to hair loss and their therapy options. Callender emphasized that visiting the dermatologist as soon as one recognized hair loss signs could limit progression and help identify any underlying medical issues.

A common type of hair loss, central centrifugal cicatricial alopecia, triggers hair loss at the center of the scalp. This condition affects almost 15% of Black females. Early detection of this type of alopecia is important, as the condition destroys hair follicles and causes scarring. This makes it hard for hair to grow back, leading to permanent loss of hair.

Callender also explained that high cholesterol, hypertension, diabetes, acne and breast cancer were prevalent among Black females suffering from central centrifugal cicatricial alopecia. She also noted that most women suffering from hair loss suffered from acne due to increased hormones. Callender added that hypertension as well as menopause were also common while hair loss in women progressed.

Treatment for central centrifugal cicatricial alopecia often includes topical steroid medication or corticosteroid injections and antibiotics, which offers patients pain relief and prevents the scars from worsening. Minoxidil is also a potential treatment for hair loss. This therapy reduces hair loss by strengthening the remaining hair strands and stimulating hair growth. While one can purchase products that contain this active ingredient the pharmacy, those in need of higher doses will need to visit a dermatologist for a prescription.

Callender stated that hair product ingredients were important, noting that some shampoos could dry hair out and cause breakage. Hair and shampoo products should include moisturizing ingredients such as jojoba oil, vitamin E and A, as well as shea butter.

In cases where treatments weren’t effective in preventing hair loss, the professor noted that transplants could be prescribed as a permanent solution by one’s dermatologist.

Many products from entities such as Jupiter Wellness Inc. (NASDAQ: JUPW) are geared at helping people turn back or slow hair loss, so individuals can find options as they seek to deal with hair loss resulting from a variety of causes.

NOTE TO INVESTORS: The latest news and updates relating to Jupiter Wellness Inc. (NASDAQ: JUPW) are available in the company’s newsroom at https://ibn.fm/JUPW

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care

Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…

16 hours ago

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline

High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…

18 hours ago

Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells

Most existing cancer treatments not only attack cancer cells but also adversely impact healthy body cells. The…

2 days ago

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

3 days ago

Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy

Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent…

6 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships

LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and…

6 days ago